We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Ambev
ABEV
$46.5B
| $362K | ﹤0.01% |
62,841
+841
| +1% | +$5.22K |
|
2502
Kopin
KOPN
$756M
| $362K | ﹤0.01% |
102,914
+4,400
| +4% | +$17K |
|
2503
Kratos Defense & Security Solutions
KTOS
$10.8B
| $362K | ﹤0.01% |
65,551
+6,025
| +10% | +$32.5K |
|
|
LMOS
2504
DELISTED
Lumos Networks Corp
LMOS
| $362K | ﹤0.01% |
23,729
+4,700
| +25% | +$79.2K |
|
2505
York Water
YORW
$512M
| $361K | ﹤0.01% |
14,866
+1,900
| +15% | +$44.7K |
|
|
LGTY
2506
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $361K | ﹤0.01% |
35,371
+4,700
| +15% | +$43.5K |
|
2507
Arrowhead Research
ARWR
$12.1B
| $360K | ﹤0.01% |
53,220
+11,650
| +28% | +$82.7K |
|
|
BFIN
2508
DELISTED
BankFinancial
BFIN
| $359K | ﹤0.01% |
27,313
+1,200
| +5% | +$14.3K |
|
2509
Vanda Pharmaceuticals
VNDA
$308M
| $359K | ﹤0.01% |
38,645
+9,625
| +33% | +$109K |
|
|
MGI
2510
DELISTED
MoneyGram International, Inc. New
MGI
| $359K | ﹤0.01% |
41,549
+2,000
| +5% | +$17.4K |
|
|
ACI
2511
DELISTED
ARCH COAL, INC.
ACI
| $359K | ﹤0.01% |
35,929
+1,603
| +5% | +$18.6K |
|
|
CHUY
2512
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $358K | ﹤0.01% |
15,908
+2,400
| +18% | +$52.7K |
|
2513
PC Connection
CNXN
$2.19B
| $357K | ﹤0.01% |
13,665
+700
| +5% | +$17.2K |
|
|
ITCI
2514
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $357K | ﹤0.01% |
14,955
+2,800
| +23% | +$62.7K |
|
|
POT
2515
DELISTED
Potash Corp Of Saskatchewan
POT
| $357K | ﹤0.01% |
11,071
-1,100
| -9% | -$38.7K |
|
|
IMBI
2516
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $356K | ﹤0.01% |
5,311
+460
| +9% | +$29.7K |
|
|
LIOX
2517
DELISTED
Lionbridge Technologies
LIOX
| $356K | ﹤0.01% |
62,262
+12,200
| +24% | +$67K |
|
|
OSIR
2518
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $356K | ﹤0.01% |
20,234
+2,100
| +12% | +$35.3K |
|
2519
Barrett Business Services
BBSI
$813M
| $355K | ﹤0.01% |
+33,120
| New | +$300K |
|
2520
Ducommun
DCO
$3.04B
| $354K | ﹤0.01% |
13,651
+1,225
| +10% | +$31.7K |
|
|
AHRT
2521
AH Realty Trust
AHRT
$515M
| $353K | ﹤0.01% |
33,113
+1,800
| +6% | +$19K |
|
|
GIFI
2522
DELISTED
Gulf Island Fabrication
GIFI
| $353K | ﹤0.01% |
23,764
+1,700
| +8% | +$27.6K |
|
|
LADR
2523
Ladder Capital
LADR
$1.21B
| $353K | ﹤0.01% |
23,795
+623
| +3% | +$9.34K |
|
|
LION
2524
DELISTED
Fidelity Southern Corporation
LION
| $353K | ﹤0.01% |
20,917
+1,100
| +6% | +$17.6K |
|
2525
Extreme Networks
EXTR
$3.18B
| $351K | ﹤0.01% |
110,991
+14,500
| +15% | +$47.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.